SMYD2 regulates transcription, inhibits the tumor suppressor proteins p53 and retinoblastoma protein (RB1), and enhances the poly (ADP-ribose) activity of the oncogenic protein PARP1 in cancer cells [60]. Here, RB1 is linked to cancer.